Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Shares Purchased by M&T Bank Corp

M&T Bank Corp raised its holdings in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 2.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 51,827 shares of the real estate investment trust’s stock after buying an additional 1,059 shares during the period. M&T Bank Corp’s holdings in Sabra Healthcare REIT were worth $905,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. VSM Wealth Advisory LLC purchased a new position in shares of Sabra Healthcare REIT in the 4th quarter valued at $26,000. UMB Bank n.a. raised its position in Sabra Healthcare REIT by 379.6% in the first quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust’s stock valued at $36,000 after purchasing an additional 1,621 shares during the period. Fifth Third Bancorp raised its position in Sabra Healthcare REIT by 110.3% in the first quarter. Fifth Third Bancorp now owns 3,835 shares of the real estate investment trust’s stock valued at $67,000 after purchasing an additional 2,011 shares during the period. GF Fund Management CO. LTD. acquired a new position in shares of Sabra Healthcare REIT during the fourth quarter worth about $74,000. Finally, Harbor Capital Advisors Inc. boosted its position in shares of Sabra Healthcare REIT by 17.2% in the first quarter. Harbor Capital Advisors Inc. now owns 4,377 shares of the real estate investment trust’s stock worth $76,000 after buying an additional 642 shares during the period. 99.40% of the stock is currently owned by hedge funds and other institutional investors.

Sabra Healthcare REIT Price Performance

Shares of NASDAQ SBRA opened at $18.76 on Tuesday. The company has a quick ratio of 4.22, a current ratio of 4.22 and a debt-to-equity ratio of 0.89. Sabra Healthcare REIT, Inc. has a fifty-two week low of $15.60 and a fifty-two week high of $20.03. The business has a 50 day moving average price of $18.00 and a two-hundred day moving average price of $17.37. The firm has a market cap of $4.46 billion, a PE ratio of 31.80, a price-to-earnings-growth ratio of 1.53 and a beta of 0.85.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings results on Monday, May 5th. The real estate investment trust reported $0.37 earnings per share for the quarter, topping analysts’ consensus estimates of $0.36 by $0.01. The business had revenue of $183.54 million during the quarter, compared to the consensus estimate of $180.23 million. Sabra Healthcare REIT had a net margin of 19.55% and a return on equity of 5.14%. The business’s quarterly revenue was up 10.1% compared to the same quarter last year. During the same quarter last year, the company earned $0.35 earnings per share. Sell-side analysts expect that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, May 30th. Stockholders of record on Friday, May 16th were given a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, May 16th. This represents a $1.20 annualized dividend and a dividend yield of 6.40%. Sabra Healthcare REIT’s payout ratio is 203.39%.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the company. Scotiabank raised their target price on Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a “sector perform” rating in a report on Monday, June 23rd. Truist Financial increased their price objective on shares of Sabra Healthcare REIT from $17.00 to $18.00 and gave the company a “hold” rating in a research report on Tuesday, March 18th. Three research analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $19.67.

Insider Buying and Selling

In other Sabra Healthcare REIT news, Director Michael J. Foster sold 11,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $18.22, for a total transaction of $200,420.00. Following the sale, the director owned 64,725 shares in the company, valued at $1,179,289.50. This represents a 14.53% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Company insiders own 1.10% of the company’s stock.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.